ibopamine has been researched along with cardiovascular agents in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brendel, E; de Mey, C; Enterling, D; Wesche, H | 1 |
Burri, M; Kehtari, R; Metzger, J; Reuge, L | 1 |
Poole-Wilson, PA; van Veldhuisen, DJ | 1 |
2 review(s) available for ibopamine and cardiovascular agents
Article | Year |
---|---|
[Chronic cardiac insufficiency: current treatment and future outlook].
Topics: Adrenergic Antagonists; Aldosterone; Angiotensin II; Cardiotonic Agents; Cardiovascular Agents; Clinical Protocols; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Vasoconstrictor Agents | 1996 |
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure.
Topics: Bosentan; Cardiovascular Agents; Deoxyepinephrine; Heart Failure; Humans; Imidazoles; Mibefradil; Pyrazines; Quinolines; Sulfonamides; Xamoterol | 2001 |
1 other study(ies) available for ibopamine and cardiovascular agents
Article | Year |
---|---|
Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man.
Topics: Adult; Cardiovascular Agents; Deoxyepinephrine; Dopamine; Drug Interactions; Electrocardiography; Humans; Male; Phonocardiography; Quinidine | 1988 |